Kidney Cancer Guide: Treatment CCI-779

Treatments

All Treatments Targeted Therapy Immunotherapy Anti-Angiogenesis Genetic Therapy Chemotherapy Radiotherapy Laser Therapy Surgery Biophosphonates Hormonal Supplements Alternative Other Adjuvant *Treatment Enhancers

Treatments List

Treatment Category Profile

Treatment Name: CCI-779 Known as:

Also Known As: CCI-779

Treatment Type: Hormone Therapy Status: FDA Approved (phase II)

This drug inhibits abnormal cell growth and division by targeting mTOR protein kinase, which is involved in cell-cycle regulation. Key proteins in the mTOR pathway are essential to cell division, allowing CCI-779 to selectively arrest development of some cancer cells. In trials, the main side effects are skin and mucosal.

Articles related to this Treatment

1 FDA Grants Fast-Track Development Status to CCI-779 for Renal Cell Carcinoma Doctor's Guide Mar 6, 2002

2 New Drug Shows Promise in Cancer Tests Yahoo News Oct 13, 2000

3 CCI-779 shows positive safety profile and potential anti-tumor activity EurekAlert Oct 13, 2000

4 My Mom-CCI779 Update Lori Raphael <loriraphael@hotmail.com> Oct 7, 2000

All Treatments

01. Targeted Therapy

02. Immunotherapy

03. Anti-Angiogenesis

04. Genetic Therapy

05. Chemotherapy

06. Radiotherapy

07. Laser Therapy

08. Surgery

09. Biophosphonates

10. Hormonal

11. Supplements

12. Alternative

13. Other

14. Adjuvent

15. *Enhancers

Treatment Name:	CCI-779	Known as: Also Known As:	CCI-779
Treatment Type:	Hormone Therapy	Status:	FDA Approved (phase II)
This drug inhibits abnormal cell growth and division by targeting mTOR protein kinase, which is involved in cell-cycle regulation. Key proteins in the mTOR pathway are essential to cell division, allowing CCI-779 to selectively arrest development of some cancer cells. In trials, the main side effects are skin and mucosal.